Affirming only pushback continues.
A few interesting papers that lead to other interesting papers. This post will contain links but I hope to add more later.
The Dutch Model is falling apart
By Stella O'Malley / 2 January 2023
First, Stella O’Malley writes about an article in Nederlands that is throwing a great deal of light on the Dutch Protocol. It also seems that there will be a review of the patients that the Dutch team had not previously included in their papers.
This article in the Nederlands points out the dangers on only using a nation’s own sources with no international input or even wide review.
genspect.org/the-dutch-model-is-falling-apart/
Then SEGM has published on Colin Wright’s substack a version of their previously published article.
5 False Assumptions Behind Youth Gender Transitions
2nd Jan 2023
www.realityslaststand.com/p/5-false-assumptions-behind-youth
Here is the original
segm.org/false-assumptions-gender-affirmation-minors
( segm.org )
[This reviewed Stephen M. Rosenthal‘s paper in Nature, 10 August 2021:
“Challenges in the care of transgender and gender-diverse youth: an endocrinologist’s view”
www.nature.com/articles/s41574-021-00535-9 ]
[note: there is a paper rebutting this one linked below]
The five unproven assumptions are:
Unproven Assumption 1: Gender identity, which underlies gender dysphoria, is a fundamental personal characteristic that is biologically “ingrained.”
Unproven Assumption 2: The sharp rise in the number of youth presenting with gender dysphoria does not signal a true increase in cases—it’s merely better detection.
False Assumption 3: Medical interventions in gender-dysphoric minors have clear eligibility criteria.
False Assumption 4: Medical interventions for gender dysphoric minors have been demonstrated to be safe and effective.
Unproven Assumption 5: Detransition does not represent medical harm and is rare.
This has then had quite a few interesting links.
www.tandfonline.com/doi/full/10.1080/0092623X.2022.2160396?src=
Some Limitations of “Challenges in the Care of Transgender and Gender-Diverse Youth: An Endocrinologist’s View”
from J. Cohn, Published online: 24 Dec 2022
Abstract:
There is significant disagreement about how to support trans-identified or gender-dysphoric young people. Different experts and expert bodies make strikingly different recommendations based upon the same (limited) evidence. The US-originating “gender-affirmative” model emphasizes social transition and medical intervention, while some other countries, in response to evidence reviews of medical intervention outcomes, have adopted psychological interventions as the first line of treatment. A proposed model of gender-affirming care, comprising only medical intervention for “eligible” youth, is described in Rosenthal (2021). Determining eligibility for these medical interventions is challenging and engenders considerable disagreement among experts, neither of which is mentioned. The review also claims without support that medical interventions have been shown to clearly benefit mental health, and leaves out significant risks and less invasive alternatives. The unreliability of outcome studies and the corresponding uncertainties as to how gender dysphoria develops and responds to treatment are also unreported.
This has many other links to follow.
Then there was this review of US Military health insurance records for transition persistence.
academic.oup.com/jcem/article-abstract/107/9/e3937/6572526?redirectedFrom=fulltext&login=false
”Continuation of Gender-affirming Hormones Among Transgender Adolescents and Adults”
Christina M Roberts,
David A Klein, Terry A Adirim,
Natasha A Schvey, Elizabeth Hisle-Gorman
22 April 2022
Results
The study sample included 627 transmasculine and 325 transfeminine individuals with an average age of 19.2 ± 5.3 years. The 4-year gender-affirming hormone continuation rate was 70.2% (95% CI, 63.9-76.5). Transfeminine individuals had a higher continuation rate than transmasculine individuals 81.0% (72.0%-90.0%) vs 64.4% (56.0%-72.8%). People who started hormones as minors had higher continuation rate than people who started as adults 74.4% (66.0%-82.8%) vs 64.4% (56.0%-72.8%). Continuation was not associated with household income or family member type. In Cox regression, both transmasculine gender identity (hazard ratio, 2.40; 95% CI, 1.50-3.86) and starting hormones as an adult (hazard ratio, 1.69; 95% CI, 1.14-2.52) were independently associated with increased discontinuation rates.
I can only hope that Dr Cass has seen these and found them interesting too.